Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free BAYRY Stock Alerts

Bayer Aktiengesellschaft (BAYRY) Short Interest Ratio & Short Volume

Bayer Aktiengesellschaft logo
$14.08 -0.10 (-0.71%)
As of 09/23/2026 03:59 PM Eastern
Compare

Bayer Aktiengesellschaft Short Interest Overview

As of August 31, 2026, Bayer Aktiengesellschaft (BAYRY) had a short interest of 127,301 shares sold short, representing 0.00% of the public float. This marks a -80.77% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 395,938 shares to cover all short positions.

Current Short Interest
127,301 shares
Previous Short Interest
661,820 shares
Change Vs. Previous Month
-80.77%
Dollar Volume Sold Short
$1.82 million
Short Interest Ratio
0.2 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
3,930,000,000 shares
Short Percent of Float
0.00%
Today's Trading Volume
365,589 shares
Average Trading Volume
395,938 shares
Today's Volume Vs. Average
92%
Short Selling Bayer Aktiengesellschaft?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BAYRY Short Interest Over Time

BAYRY Days to Cover Over Time

BAYRY Percentage of Float Shorted Over Time

Bayer Aktiengesellschaft Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2026127,301 shares $1.82 million -80.8%0.0%0.18 $14.26
8/14/2026661,820 shares $9.16 million +26.6%0.0%0.36 $13.84
7/31/2026522,716 shares $7.26 million +94.9%0.0%0.39 $13.89
7/15/2026268,144 shares $3.65 million +88.7%0.0%0.15 $13.60
6/30/2026142,122 shares $1.95 million +24.7%0.0%0.07 $13.70
6/15/2026113,957 shares $1.19 million +57.0%0.0%0.04 $10.44
5/29/202672,572 shares $765.63 thousand -29.5%0.0%0.03 $10.55
5/15/2026102,885 shares $1.12 million +44.0%0.0%0.04 $10.90
4/30/202671,460 shares $798.21 thousand -21.5%0.0%0.03 $11.17
4/15/202690,984 shares $1.09 million -57.9%0.0%0.04 $11.96
3/31/2026216,042 shares $2.48 million +74.5%0.0%0.13 $11.48
3/13/2026123,788 shares $1.36 million +178.9%0.0%0.06 $10.99
2/27/202644,387 shares $545.96 thousand -49.2%0.0%0.01 $12.30
2/13/202687,354 shares $1.19 million -18.9%0.0%0.03 $13.58
1/30/2026107,738 shares $1.42 million +93.0%N/A0.05 $13.15
1/15/202655,812 shares $679.23 thousand -44.5%N/A0.05 $12.17
12/31/2025100,600 shares $1.09 million +164.7%0.0%0.15 $10.82
12/15/202538,010 shares $400.25 thousand +9.3%0.0%0.03 $10.53
11/28/202534,777 shares $306.21 thousand -62.8%0.0%0.04 $8.81
11/14/202593,390 shares $764.86 thousand +99.6%0.0%0.1 $8.19
10/31/202546,780 shares $362.55 thousand -60.3%0.0%0.06 $7.75
10/15/2025117,800 shares $928.26 thousand -46.8%0.0%0.1 $7.88
9/30/2025221,500 shares $1.84 million +209.8%N/A0.3 $8.29
9/15/202571,500 shares $576.29 thousand -69.5%N/A0.1 $8.06
8/31/2025234,600 shares $1.93 million +1.1%0.0%0.4 $8.22
8/15/2025232,000 shares $1.83 million +93.7%N/A0.1 $7.90
7/31/2025119,800 shares $927.25 thousand -49.0%0.0%0.1 $7.74
7/15/2025234,700 shares $1.86 million +134.5%N/A0.3 $7.92
6/30/2025100,100 shares $754.75 thousand +35.8%0.0%0.1 $7.54
6/15/202573,700 shares $580.02 thousand -71.0%0.0%0.1 $7.87
5/31/2025254,300 shares $1.80 million -20.1%0.0%0.2 $7.06
5/15/2025318,100 shares $2.04 million +122.5%0.0%0.2 $6.42
4/30/2025143,000 shares $942.37 thousand -81.4%N/A0.2 $6.59
4/15/2025768,300 shares $4.52 million +90.1%0.0%0.5 $5.88
3/31/2025404,200 shares $2.43 million -2.8%0.0%0.4 $6.02
3/15/2025415,800 shares $2.64 million -48.2%0.0%0.3 $6.36
2/28/2025803,100 shares $4.76 million +5.3%0.0%0.7 $5.93
2/15/2025762,900 shares $4.31 million -50.3%0.0%0.4 $5.65
1/31/20251,536,000 shares $8.66 million +243.1%N/A0.8 $5.64
1/15/2025447,700 shares $2.39 million +412.2%N/A0.2 $5.34
Elon gets it. Do you? (Ad)

Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel

Stream the free Ignition Point broadcast for the full biotech breakdown.
12/31/202487,400 shares $426.51 thousand -4.7%N/A0 $4.88
12/15/202491,700 shares $473.17 thousand -33.8%N/A0 $5.16
11/30/2024138,600 shares $711.02 thousand +34.8%N/A0 $5.13
11/15/2024102,800 shares $551.01 thousand +1.1%N/A0 $5.36
10/31/2024101,700 shares $688.86 thousand +32.4%N/A0.1 $6.77
10/15/202476,800 shares $555.26 thousand -20.7%N/A0.1 $7.23
9/30/202496,900 shares $820.74 thousand -55.1%N/A0.1 $8.47
9/15/2024215,900 shares $1.62 million +48.1%N/A0.2 $7.51
8/31/2024145,800 shares $1.13 million +43.4%N/A0.1 $7.72
8/15/2024101,700 shares $749.53 thousand -5.8%N/A0 $7.37
7/31/2024107,900 shares $804.93 thousand +144.7%N/A0.1 $7.46
7/15/202444,100 shares $313.99 thousand -64.3%N/A0 $7.12
6/30/2024123,400 shares $868.74 thousand +34.1%N/A0.1 $7.04
6/15/202492,000 shares $666.08 thousand -58.8%N/A0.1 $7.24
5/31/2024223,200 shares $1.72 million +42.3%N/A0.1 $7.72
5/15/2024156,900 shares $1.26 million -82.8%N/A0.1 $8.02
4/30/2024911,000 shares $6.65 million +68.3%N/A0.2 $7.30
4/15/2024541,300 shares $3.80 million +22.7%N/A0.1 $7.02
3/31/2024441,200 shares $3.38 million +132.8%N/A0.1 $7.66
3/15/2024189,500 shares $1.35 million +188.0%N/A0.1 $7.14
2/29/202465,800 shares $500.08 thousand -88.0%N/A0 $7.60
2/15/2024550,200 shares $4.19 million +67.6%N/A0.2 $7.62
1/15/2024669,600 shares $6.32 million +1,001.3%N/A0.2 $9.44
12/31/202360,800 shares $561.18 thousand +141.3%N/A0 $9.23
12/15/202325,200 shares $218.48 thousand +41.6%N/A0 $8.67
11/30/202317,800 shares $151.66 thousand -95.2%N/A0 $8.52
11/15/2023372,500 shares $4.16 million +1,184.5%N/A0.2 $11.16
10/31/202329,000 shares $311.75 thousand +33.6%N/A0 $10.75
10/15/202321,700 shares $247.38 thousand -1.8%N/A0 $11.40
9/30/202322,100 shares $265.20 thousand -93.7%N/A0 $12.00
9/15/2023347,800 shares $4.58 million +404.1%N/A0.2 $13.17
8/31/202369,000 shares $945.99 thousand -83.1%N/A0 $13.71
8/15/2023408,700 shares $5.79 million +1,783.4%N/A0.3 $14.16
7/31/202321,700 shares $316.82 thousand -79.3%N/A0 $14.60
7/15/2023104,800 shares $1.48 million +5.7%N/A0.1 $14.11
6/30/202399,200 shares $1.37 million -14.3%N/A0.1 $13.82
6/15/2023115,800 shares $1.64 million +64.0%N/A0.1 $14.18
5/31/202370,600 shares $986.99 thousand -77.3%N/A0.1 $13.98
5/15/2023310,400 shares $4.53 million +378.3%N/A0.2 $14.60
4/30/202364,900 shares $1.06 million -62.9%N/A0.1 $16.34
4/15/2023175,000 shares $2.96 million -54.3%N/A0.2 $16.91
3/31/2023382,600 shares $6.09 million +27.9%N/A0.2 $15.93
3/15/2023299,100 shares $4.44 million -1.6%N/A0.1 $14.86
2/28/2023304,000 shares $4.52 million -5.9%N/A0.3 $14.87
2/15/2023323,000 shares $5.19 million -4.3%N/A0.2 $16.07
1/31/2023337,600 shares $5.26 million +463.6%N/A0.3 $15.58
1/15/202359,900 shares $935.04 thousand +755.7%N/A0 $15.61
12/30/20227,000 shares $90.02 thousand -96.2%N/A0 $12.86
12/15/2022184,400 shares $2.48 million -67.2%N/A0.2 $13.44
11/30/2022561,800 shares $8.18 million +21.8%N/A0.6 $14.56
Elon gets it. Do you? (Ad)

Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel

Stream the free Ignition Point broadcast for the full biotech breakdown.
11/15/2022461,200 shares $6.35 million +2,612.9%N/A0.3 $13.76
10/31/202217,000 shares $223.38 thousand +112.5%N/A0 $13.14
10/15/20228,000 shares $95.28 thousand -97.3%N/A0 $11.91
9/30/2022296,300 shares $3.43 million -25.3%N/A0.2 $11.56
9/15/2022396,500 shares $5.28 million +190.7%N/A0.2 $13.31
8/31/2022136,400 shares $1.80 million +74.2%N/A0.1 $13.20
8/15/202278,300 shares $1.07 million -53.7%N/A0 $13.65
7/31/2022169,100 shares $2.46 million -63.3%N/A0.1 $14.52
7/15/2022460,800 shares $6.45 million +196.1%N/A0.4 $14.00
6/30/2022155,600 shares $2.31 million -44.9%N/A0.1 $14.87
6/15/2022282,400 shares $4.72 million +109.7%N/A0.2 $16.73
5/31/2022134,700 shares $2.40 million -17.0%N/A0.2 $17.82
5/15/2022162,200 shares $2.61 million +57.8%N/A0.1 $16.07
4/30/2022102,800 shares $1.68 million -55.7%N/A0.1 $16.39
4/15/2022232,200 shares $4.21 million +99.8%N/A0.2 $18.15
3/31/2022116,200 shares $1.99 million -51.0%N/A0.1 $17.12
3/15/2022236,900 shares $3.65 million +51.1%N/A0.2 $15.39
2/28/2022156,800 shares $2.27 million -16.4%N/A0.2 $14.47
2/15/2022187,600 shares $2.88 million -34.2%N/A0.2 $15.37
1/31/2022285,000 shares $4.29 million +223.9%N/A0.2 $15.07
1/15/202288,000 shares $1.33 million +3,284.6%N/A0.1 $15.06
12/31/20212,600 shares $34.48 thousand No ChangeN/A0 $13.26
12/15/20212,600 shares $33.80 thousand -97.4%N/A0 $13.00
11/30/2021100,600 shares $1.27 million -42.9%N/A0.1 $12.62
11/15/2021176,300 shares $2.53 million -19.2%N/A0.2 $14.36
10/29/2021218,300 shares $3.10 million -15.9%N/A0.3 $14.18
10/15/2021259,700 shares $3.63 million -39.5%N/A0.3 $13.98
9/30/2021429,100 shares $5.84 million +260.3%N/A0.3 $13.60

BAYRY Short Interest - Frequently Asked Questions

Short interest is the volume of Bayer Aktiengesellschaft shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 127,301 shares of BAYRY short. 0.00% of Bayer Aktiengesellschaft's shares are currently sold short. Learn More on Bayer Aktiengesellschaft's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BAYRY shares currently have a short interest ratio of 0.2. Learn More on Bayer Aktiengesellschaft's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Bayer Aktiengesellschaft's floating shares are currently sold short.

Bayer Aktiengesellschaft saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 127,301 shares, a drop of 80.8% from the previous total of 661,820 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Bayer Aktiengesellschaft's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Bayer Aktiengesellschaft: Novo Nordisk A/S (0.71%), Pfizer Inc. (2.68%), Bristol Myers Squibb Company (2.16%), Sanofi (0.34%), GSK PLC Sponsored ADR (0.74%), Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (0.00%), Takeda Pharmaceutical Co. (0.13%), Teva Pharmaceutical Industries Ltd. (3.25%), UCB SA (0.00%), UCB SA (0.59%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling BAYRY is an investing strategy that aims to generate trading profit from Bayer Aktiengesellschaft as its price is falling. BAYRY shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bayer Aktiengesellschaft occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BAYRY, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BAYRY, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BAYRY:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:BAYRY is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Everyone remembers January's silver spike. Then what?
Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...
i2i Marketing Group, LLC | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel